Liver fibrosis

Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin

Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323

The Versatile Role of microRNA-30a in Human Cancer

Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,414

Natural history of liver fibrosis progression in patients with chronic hepatitis C

Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011

Nonalcoholic Steatohepatitis

Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903

J. Submicrosc. Cytol. Pathol.

Thomas, A. C., & Campbell, J. H. (2000) · Cited by 2,800

Epithelial-mesenchymal transition and its implications for fibrosis

Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20530 · Cited by 2,715

Epithelial-mesenchymal transition and its implications for fibrosis

Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,171

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

Regev, A., Berho, M. E., Jeffers, L. J., Milikowski, C., Molina, E. G., Pyrsopoulos, N., Feng, Z.-Z., Reddy, K. R., & Schiff, E. R. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.06038.x · Cited by 2,078

Hepatogastroenterology

Xu, D., He, X., Chang, Y., Sun, S., Xu, C., & Lin, J. (2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977

Liver fibrosis – from bench to bedside

Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780

Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options

Gressner, O. A., Weiskirchen, R., & Gressner, A. M. (2007) · Comparative Hepatology · doi:10.1186/1476-5926-6-7 · Cited by 136

PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis

Pingitore, P., Dongiovanni, P., Motta, B. M., Meroni, M., Lepore, S. M., Mancina, R. M., Pelusi, S., Russo, C., Caddeo, A. M., Rossi, G. E., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw341 · Cited by 136

The roles and mechanisms of hypoxia in liver fibrosis

Cai, J., Hu, M., Chen, Z., & Ling, Z. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02854-x · Cited by 136

Modulation of extracellular matrix turnover in the trabecular meshwork

Fuchshofer, R., & Tamm, E. R. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.01.005 · Cited by 136

Roles of mTOR Signaling in Tissue Regeneration

Wei, X., Luo, L., & Chen, J.-Z. (2019) · Cells · doi:10.3390/cells8091075 · Cited by 136

Hepatic activation of IKK/NFκB signaling induces liver fibrosis via macrophage-mediated chronic inflammation

Sunami, Y., Leithäuser, F., Gul, S., Fiedler, K., Güldiken, N., Espenlaub, S., Holzmann, K., Hipp, N., Sindrilaru, A., Luedde, T., et al. (2012) · Hepatology · doi:10.1002/hep.25711 · Cited by 135

Inhibition of hepatic fibrogenesis by matrix metalloproteinase‐9 mutants in mice

Roderfeld, M., Weiskirchen, R., Wagner, S., Berres, M., Henkel, C., Grötzinger, J., Gressner, A. M., Matern, S., & Roeb, E. (2006) · The FASEB Journal · doi:10.1096/fj.05-4828com · Cited by 135

CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation

Hintermann, E., Bayer, M., Pfeilschifter, J. M., Luster, A. D., & Christen, U. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.09.003 · Cited by 135

The Epidermal Growth Factor Receptor: A Link Between Inflammation and Liver Cancer

Berasain, C., Perugorria, M. J., Latasa, M. U., Castillo, J., Goñi, S., Santamaría, M., Prìeto, J., & Avila, M. A. (2009) · Experimental Biology and Medicine · doi:10.3181/0901-mr-12 · Cited by 134

Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats

Kaji, K., Yoshiji, H., Ikenaka, Y., Noguchi, R., Aihara, Y., Douhara, A., Moriya, K., Kawaratani, H., Shirai, Y., Yoshii, J., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0783-4 · Cited by 134

Lipopolysaccharide mediates hepatic stellate cell activation by regulating autophagy and retinoic acid signaling

Chen, M., Liu, J., Yang, W., & Ling, W. (2017) · Autophagy · doi:10.1080/15548627.2017.1356550 · Cited by 134

Senescent cells: Living or dying is a matter of NK cells

Antonangeli, F., Zingoni, A., Soriani, A., & Santoni, A. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0718-299r · Cited by 134

Reduction of Advanced Liver Fibrosis by Short-Term Targeted Delivery of An Angiotensin Receptor Blocker to Hepatic Stellate Cells in Rats

Moreno, M., Gonzalo, T., Kok, R. J., Sancho‐Bru, P., van Beuge, M. M., Swart, J., Prakash, J., Temming, K., Fondevila, C., Beljaars, L., et al. (2009) · Hepatology · doi:10.1002/hep.23419 · Cited by 134

Disease‐Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium

Evers, R., Piquette‐Miller, M., Polli, J. W., Rüssel, F. G. M., Sprowl, J. A., Tohyama, K., Ware, J. A., de Wildt, S. N., Xie, W., & Brouwer, K. L. R. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1115 · Cited by 132

Oxidative Stress and Redox Signaling in the Pathophysiology of Liver Diseases

Mooli, R. G. R., Mukhi, D., & Ramakrishnan, S. K. (2022) · Comprehensive physiology · doi:10.1002/cphy.c200021 · Cited by 134

Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis

Krishnan, A., Li, X., Kao, W.-Y., Viker, K., Butters, K. A., Masuoka, H. C., Knudsen, B. E., Gores, G. J., & Charlton, M. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.121 · Cited by 132

Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection

Larrubia, J. R., Martínez, S. B., Calvino, M., Sanz‐de‐Villalobos, E., & Parra-Cid, T. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.7149 · Cited by 132

Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease

Beaven, S. W., Wroblewski, K., Wang, J., Hong, C., Bensinger, S., Tsukamoto, H., & Tontonoz, P. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.053 · Cited by 131

Asiatic Acid Inhibits Liver Fibrosis by Blocking TGF-beta/Smad Signaling In Vivo and In Vitro

Tang, L., He, R.-H., Yang, G., Jia-ju, T., Zhou, L., Meng, X.-M., Huang, X. R., & Lan, H. Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031350 · Cited by 131

STAT3 NH2-Terminal Acetylation Is Activated by the Hepatic Acute-Phase Response and Required for IL-6 Induction of Angiotensinogen

Ray, S., Boldogh, I. R., & Brasier, A. R. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.07.055 · Cited by 131

The etiology of liver damage imparts cytokines transforming growth factor β1 or interleukin-13 as driving forces in fibrogenesis #

Weng, H., Liu, Y., Chen, J., Huang, T., Xu, L., Godoy, P., Hu, J.-H., Zhou, C., Stickel, F., Marx, A., et al. (2009) · Hepatology · doi:10.1002/hep.22934 · Cited by 131

Biomarker-Based Approaches for Assessing Alcohol Use Disorders

Niemelä, O. J. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13020166 · Cited by 131

Human hepatic stellate cell isolation and characterization

Shang, L., Hosseini, M., Liu, X., Kisseleva, T., & Brenner, D. A. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1404-4 · Cited by 131

The Role of the Gut Microbiome in Liver Cirrhosis Treatment

Lee, N. Y., & Suk, K. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010199 · Cited by 131

Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism

Zhang, Z., Shang, J., Yang, Q., Dai, Z., Liang, Y., Lai, C., Feng, T., Zhong, D., Zou, H., Ji, G., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01788-4 · Cited by 131

Proteasome inhibition induces hepatic stellate cell apoptosis

Anan, A., Baskin-Bey, E. S., Bronk, S. F., Werneburg, N. W., Shah, V. H., & Gores, G. J. (2006) · Hepatology · doi:10.1002/hep.21036 · Cited by 131

Mueller matrix polarimetry for improved liver fibrosis diagnosis

Dubreuil, M., Babilotte, P., Martin, L., Sevrain, D., Rivet, S., Grand, Y. L., Brun, G. L., Turlin, B., & Jeune, B. L. (2012) · Optics Letters · doi:10.1364/ol.37.001061 · Cited by 130

miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis

Roderburg, C., Luedde, M., Cardenas, D. V., Vucur, M., Mollnow, T., Zimmermann, H. W., Koch, A. H., Hellerbrand, C., Weiskirchen, R., Frey, N., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.022 · Cited by 130

Hepatocyte-Derived Snail1 Propagates Liver Fibrosis Progression

Rowe, R. G., Lin, Y., Shimizu‐Hirota, R., Hanada, S., Neilson, E. G., Greenson, J. K., & Weiss, S. J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01218-10 · Cited by 131

Organ Fibrosis and Autoimmunity: The Role of Inflammation in TGFβ-Dependent EMT

Sisto, M., Ribatti, D., & Lisi, S. (2021) · Biomolecules · doi:10.3390/biom11020310 · Cited by 130

Inactivation of the Deubiquitinase CYLD in Hepatocytes Causes Apoptosis, Inflammation, Fibrosis, and Cancer

Nikolaou, K., Tsagaratou, A., Eftychi, C., Kollias, G. A., Mosialos, G., & Talianidis, I. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.026 · Cited by 129

Expression of activation‐induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis

Kou, T., Marusawa, H., Kinoshita, K., Endo, Y., Okazaki, I., Ueda, Y., Kodama, Y., Haga, H., Ikai, I., & Chiba, T. (2006) · International Journal of Cancer · doi:10.1002/ijc.22292 · Cited by 129

The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies

Xu, J., Liu, X., Koyama, Y., Wang, P., Lan, T., Kim, I., Kim, I. H., Ma, H., & Kisseleva, T. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00167 · Cited by 130

MANF regulates metabolic and immune homeostasis in ageing and protects against liver damage

Sousa‐Victor, P., Neves, J., Cedron-Craft, W., Ventura, P. B., Liao, C., Riley, R. R., Soifer, I., van Bruggen, N., Kolumam, G. A., Villeda, S., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0023-6 · Cited by 129

Critical role of tumor necrosis factor receptor 1, but not 2, in hepatic stellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesis

Tarrats, N., Moles, A., Morales, A., García-Ruiz, C., Fernández-Checa, J. C., & Marí, M. (2011) · Hepatology · doi:10.1002/hep.24388 · Cited by 128

Liver-Specific β-Catenin Knockout Mice Exhibit Defective Bile Acid and Cholesterol Homeostasis and Increased Susceptibility to Diet-Induced Steatohepatitis

Behari, J., Yeh, T.-H., Krauland, L., Otruba, W., Cieply, B., Hauth, B., Apte, U., Wu, T., Evans, R., & Monga, S. P. S. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090667 · Cited by 128

Gut Microbiota Dysbiosis Is Associated with Inflammation and Bacterial Translocation in Mice with CCl4-Induced Fibrosis

Gómez‐Hurtado, I., Santacruz, A., Peiró, G., Zapater, P., Gutiérrez, A., Pérez‐Mateo, M., Sanz, Y., & Francés, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023037 · Cited by 128

Angiotensin-II Type 1 Receptor-Mediated Janus Kinase 2 Activation Induces Liver Fibrosis

Granzow, M., Schierwagen, R., Klein, S., Kowallick, B., Huss, S., Linhart, M., Mazar, I. G. R., Görtzen, J., Vogt, A., Schildberg, F. A., et al. (2014) · Hepatology · doi:10.1002/hep.27117 · Cited by 128

Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis

Chen, I.-S., Chen, Y., Chou, C., Chuang, R.-F., Sheen, L., & Chiu, C. (2011) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.4723 · Cited by 128

Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling pathways in activated hepatic stellate cells

Bai, T., Lian, L., Wu, Y., Wan, Y., & Nan, J. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2012.12.020 · Cited by 128

NASH and HCC

Page, J. M., & Harrison, S. A. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.007 · Cited by 128

The Use of Nanoparticles to Deliver Nitric Oxide to Hepatic Stellate Cells for Treating Liver Fibrosis and Portal Hypertension

Duong, H. T. T., Dong, Z., Su, L. C., Boyer, C. A., George, J., Davis, T. P., & Wang, J. (2015) · Small · doi:10.1002/smll.201402870 · Cited by 128

Cirrhotic portal hypertension: From pathophysiology to novel therapeutics

Gunarathne, L. S., Rajapaksha, H., Shackel, N. A., Angus, P., & Herath, C. B. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i40.6111 · Cited by 128

Amelioration of hepatic fibrosis by NK cell activation

Muhanna, N., Tair, L. A., Doron, S., Amer, J., Azzeh, M., Mahamid, M., Friedman, S., & Safadi, R. (2011) · Gut · doi:10.1136/gut.2010.211136 · Cited by 127

Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover

Simón, J., Ouro, A., Ala-Ibanibo, L., Presa, N., Delgado, T. C., & Martínez‐Chantar, M. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010040 · Cited by 127

Superparamagnetic iron oxide nanoparticles forin vivomolecular and cellular imaging

Sharifi, S., Seyednejad, H., Laurent, S., Atyabi, F., Saei, A. A., & Mahmoudi, M. (2015) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1638 · Cited by 126

Update on the pathophysiology of liver fibrosis

Pinzani, M., & Macías‐Barragán, J. (2010) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.10.47 · Cited by 126

Oncogenic Potential of Hepatitis C Virus Proteins

Banerjee, A. K., Ray, R. B., & Ray, R. (2010) · Viruses · doi:10.3390/v2092108 · Cited by 126

MicroRNA ‐101 suppresses liver fibrosis by targeting the TGF β signalling pathway

Tu, X., Zhang, H., Zhang, J., Zhao, S., Zheng, X., Zhang, Z., Zhu, J., Chen, J., Dong, L., Zang, Y., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4373 · Cited by 126

Wnt/β-Catenin Signaling as a Potential Target for the Treatment of Liver Cirrhosis Using Antifibrotic Drugs

Nishikawa, K., Osawa, Y., & Kimura, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103103 · Cited by 126

Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways

Cheng, Q., Li, C., Yang, C., Zhong, Y., Wu, D., Shi, L., Chen, L., Li, Y., & Li, L. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.12.006 · Cited by 126

Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma—A Review

Oura, K., Morishita, A., & Masaki, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218362 · Cited by 126

The role of PI3k/AKT signaling pathway in attenuating liver fibrosis: a comprehensive review

Shamsan, E., Almezgagi, M., Gamah, M., Khan, N., Qasem, A., Chuanchuan, L., & Haining, F. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1389329 · Cited by 134

The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis

Dai, L., Li, H. Y., Guan, L.-X., Ritchie, G., & Zhou, J. X. (2008) · Stem Cell Research · doi:10.1016/j.scr.2008.07.005 · Cited by 126

The hedgehog pathway regulates remodelling responses to biliary obstruction in rats

Omenetti, A., Popov, Y. V., Jung, Y., Choi, S. S., Witek, R. P., Yang, L., Brown, K. D., Schuppan, D., & Diehl, A. M. (2008) · Gut · doi:10.1136/gut.2008.148619 · Cited by 125

Transforming growth factor β1 signaling coincides with epithelial–mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice

Shen, M., Liu, X., Zhang, H., & Guo, S.-W. (2015) · Human Reproduction · doi:10.1093/humrep/dev314 · Cited by 124

Enzyme‐linked immunosorbent serum assay specific for the 7S domain of Collagen Type IV (P4NP 7S): A marker related to the extracellular matrix remodeling during liver fibrogenesis

Leeming, D. J., Nielsen, M. J., Dai, Y., Veidal, S. S., Vassiliadis, E., Zhang, C., He, Y., Vainer, B., Zheng, Q., & Karsdal, M. A. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00946.x · Cited by 124

Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility

Li, C., Zheng, S., You, H., Liu, X., Lin, M., Yang, L., & Li, L. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.028 · Cited by 124

Deficiency of tenascin‐C attenuates liver fibrosis in immune‐mediated chronic hepatitis in mice

El-Karef, A., Yoshida, T., Gabazza, E. C., Nishioka, T., Inada, H., Sakakura, T., & Imanaka‐Yoshida, K. (2006) · The Journal of Pathology · doi:10.1002/path.2099 · Cited by 124

Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis

Kluwe, J., Wongsiriroj, N., Troeger, J. S., Gwak, G., Dapito, D. H., Pradère, J., Jiang, H., Siddiqi, M., Piantedosi, R., O’Byrne, S. M., et al. (2011) · Gut · doi:10.1136/gut.2010.209551 · Cited by 124

Retinoic Acid Signaling Sensitizes Hepatic Stellate Cells to NK Cell Killing via Upregulation of NK Cell Activating Ligand RAE1

Radaeva, S., Wang, L., Radaev, S., Jeong, W.-I., Park, O., & Gao, B. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00212.2007 · Cited by 123

Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis

Patsenker, E., Schneider, V., Ledermann, M., Saegesser, H., Dorn, C., Hellerbrand, C., & Stickel, F. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.044 · Cited by 123

Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis

Kitano, M., & Bloomston, M. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5030038 · Cited by 124

Roles of hepatic stellate cells in liver inflammation: a new perspective

Fujita, T., & Narumiya, S. (2016) · Inflammation and Regeneration · doi:10.1186/s41232-016-0005-6 · Cited by 123

Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy

Kristiansen, M. N. B., Veidal, S. S., Rigbolt, K. T. G., Tølbøl, K. S., Roth, J. D., Jelsing, J., Vrang, N., & Feigh, M. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i16.673 · Cited by 123

The Roles and Mechanisms of lncRNAs in Liver Fibrosis

He, Z., Yang, D., Fan, X., Zhang, M., Li, Y., Gu, X., & Yang, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041482 · Cited by 123

Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling

Xiang, D., Zou, J., Zhu, X., Chen, X., Luo, J., Kong, L., & Zhang, H. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153294 · Cited by 123

Connective tissue growth factor induces extracellular matrix deposition in human trabecular meshwork cells

Junglas, B., Yu, A. H. L., Welge‐Lüßen, U., Tamm, E. R., & Fuchshofer, R. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.01.008 · Cited by 123

Invasive Intraneural Interfaces: Foreign Body Reaction Issues

Lotti, F., Ranieri, F., Vadalà, G., Zollo, L., & Pino, G. D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00497 · Cited by 122

Liver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography

Zhang, Y. N., Fowler, K. J., Ozturk, A., Potu, C., Louie, A. L., Montes, V., Henderson, W. C., Wang, K., André, M. P., Samir, A. E., et al. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26716 · Cited by 122

Hepatic Stellate Cell Regulation of Liver Regeneration and Repair

Kitto, L. J., & Henderson, N. C. (2020) · Hepatology Communications · doi:10.1002/hep4.1628 · Cited by 125

Noninvasive screening for liver fibrosis and portal hypertension by transient elastography—a large single center experience

Reiberger, T., Ferlitsch, A., Payer, B. A., Pinter, M., Schwabl, P., Stift, J., Trauner, M., & Peck‐Radosavljevic, M. (2012) · Wiener klinische Wochenschrift · doi:10.1007/s00508-012-0190-5 · Cited by 122

Application and Mechanisms of Triptolide in the Treatment of Inflammatory Diseases—A Review

Yuan, K., Li, X., Lu, Q., Zhu, Q., Jiang, H., Wang, T., Huang, G., & Xu, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01469 · Cited by 121

Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats

Wei, Y., Clark, S. E., Morris, E. M., Thyfault, J. P., Uptergrove, G. M., Whaley‐Connell, A. T., Ferrario, C. M., Sowers, J. R., & Ibdah, J. A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.018 · Cited by 121

In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells

Lin, Y., Wu, C.-H., Luo, M.-H., Huang, Y., Wang, C., Shiao, M., & Huang, Y. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.10.021 · Cited by 121

How Inflammation Impinges on NAFLD: A Role for Kupffer Cells

Duarte, N., Coelho, I. C., Patarrão, R. S., Almeida, J. I., Penha-Gonçalves, C., & Macedo, M. P. (2015) · BioMed Research International · doi:10.1155/2015/984578 · Cited by 120

Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment

Yang, X., Li, Q., Liu, W., Zong, C., Wei, L., Shi, Y., & Han, Z. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-00983-5 · Cited by 120

STK4 regulates TLR pathways and protects against chronic inflammation–related hepatocellular carcinoma

Li, W., Xiao, J., Zhou, X., Xu, M., Hu, C., Xu, X., Lu, Y., Liu, C., Xue, S., Nie, L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81203 · Cited by 120

Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway

Liu, M., Xu, Y., Han, X., Yin, L., Xu, L., Qi, Y., Zhao, Y., Liu, K., & Peng, J. (2015) · Scientific Reports · doi:10.1038/srep18038 · Cited by 120

Extracellular vesicle therapeutics for liver disease

Borrelli, D. A., Yankson, K., Shukla, N., Vilanilam, G. K., Ticer, T. D., & Wolfram, J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.01.022 · Cited by 120

Regulation of hepatocyte fate by interferon-γ

Horras, C. J., Lamb, C. L., & Mitchell, K. A. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.01.001 · Cited by 120

In Hepatic Fibrosis, Liver Sinusoidal Endothelial Cells Acquire Enhanced Immunogenicity

Connolly, M. K., Bedrosian, A. S., Malhotra, A., Henning, J. R., Ibrahim, J., Vera, V., Cieza-Rubio, N. E., Hassan, B. U., Pachter, H. L., Cohen, S., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000332 · Cited by 120

Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats

Yao, Q., Xu, B., Wang, J., Liu, H., Zhang, S., & Tu, C. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-156 · Cited by 120

Alcohol Abuse: Critical Pathophysiological Processes and Contribution to Disease Burden

Molina, P. E., Gardner, J. D., Souza‐Smith, F. M., & Whitaker, A. M. (2014) · Physiology · doi:10.1152/physiol.00055.2013 · Cited by 120

Novel therapeutic targets in primary biliary cirrhosis

Dyson, J. K., Hirschfield, G. M., Adams, D. H., Beuers, U., Mann, D. A., Lindor, K. D., & Jones, D. E. J. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.12 · Cited by 120

Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension

Jalan, R., Chiara, F. D., Vairappan, B., Andreola, F., Khetan, V. U., Malagó, M., Pinzani, M., Mookerjee, R. P., & Rombouts, K. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.019 · Cited by 119

The role of integrins in TGFβ activation in the tumour stroma

Khan, Z. A., & Marshall, J. F. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2474-y · Cited by 121

Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis

Cao, Z., Ye, T., Sun, Y., Ji, G., Shido, K., Chen, Y., Luo, L., Na, F., Li, X., Huang, Z., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai8710 · Cited by 121

Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell‐to‐cell interaction and transition

Svegliati‐Baroni, G., Minicis, S. D., & Marzioni, M. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01825.x · Cited by 119

Natural killer cells and liver fibrosis

Fasbender, F., Widera, A., Hengstler, J. G., & Watzl, C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00019 · Cited by 118

Inter- and Intra-Operator Reliability and Repeatability of Shear Wave Elastography in the Liver: A Study in Healthy Volunteers

Hudson, J. M., Milot, L. M., Parry, C., Williams, R., & Burns, P. N. (2013) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2012.12.011 · Cited by 118

Clinical Features of Lysosomal Acid Lipase Deficiency

Burton, B. K., Deegan, P. B., Enns, G. M., Guardamagna, O., Horslen, S. P., Hovingh, G. K., Lobritto, S., Malinová, V., McLin, V. A., Raiman, J., et al. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000935 · Cited by 118

Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion

Wu, Y., Liu, X., Zhou, Q. Y., Huang, C., Meng, X., Xu, F., & Li, J. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.09.028 · Cited by 117

Functional Immune Anatomy of the Liver—As an Allograft

Demetris, A. J., Bellamy, C. O. C., Gandhi, C. R., Prost, S., Nakanuma, Y., & Stolz, D. B. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13749 · Cited by 117

Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress

Yang, J. H., Kim, S. C., Kim, K. M., Jang, C. H., Cho, S. S., Kim, S. J., Ku, S., Cho, I. J., & Ki, S. H. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.042 · Cited by 117

Liver progenitor cell-driven liver regeneration

So, J., Kim, A. S., Lee, S., & Shin, D. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0483-0 · Cited by 117

Peroxidasin Is Secreted and Incorporated into the Extracellular Matrix of Myofibroblasts and Fibrotic Kidney

Péterfi, Z., Donkó, Á., Orient, A., Sum, A., Prókai, Á., Molnár, B., Veréb, Z., Rajnavölgyi, É., Kovács, K., Müller, V., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080693 · Cited by 117

Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model

Chung, S. I., Moon, H., Ju, H.-L., Cho, K. J., Kim, D. Y., Han, K., Eun, J. W., Nam, S. W., Ribback, S., Dombrowski, F., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.007 · Cited by 116

Micro RNA ‐30a ameliorates hepatic fibrosis by inhibiting Beclin1‐mediated autophagy

Chen, J., Yu, Y., Li, S., Liu, Y., Zhou, S. F., Cao, S., Yin, J., & Li, G. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13278 · Cited by 116

Neutrophil extracellular traps promote MASH fibrosis by metabolic reprogramming of HSC

Xia, Y., Wang, Y., Xiong, Q., He, J., Wang, H., Islam, M., Zhou, X., Kim, A. C., Zhang, H., Huang, H., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000762 · Cited by 116

Fibrosis as a Major Mechanism of Chronic Liver Disease

Bechmann, L. P., & Friedman, S. L. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-866-9_5 · Cited by 1

Anti-fibrotic treatments for chronic liver diseases: The present and the future

Odagiri, N., Matsubara, T., Sato-Matsubara, M., Fujii, H., Enomoto, M., & Kawada, N. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0187 · Cited by 64

Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis

Kisseleva, T., & Brenner, D. A. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04658.x · Cited by 291

Liver extracellular matrix in health and disease

Bédossa, P., & Paradis, V. (2003) · The Journal of Pathology · doi:10.1002/path.1397 · Cited by 300

Pathogenesis of Liver Fibrosis

Alcolado, R., Arthur, M. J. P., & Iredale, J. P. (1997) · Clinical Science · doi:10.1042/cs0920103 · Cited by 172